To date our members have invested in the following companies:
Founded in 2017, Cumulus is the first oncology drug development accelerator in Europe. It develops new oncology treatments that target the unmet medical needs of specific cancer patient populations. Alba Equity participated in the company’s £1.7m funding round in June 2020.
Altair Medical is a UK based Digital Health company developing a wearable sensor that aims to radically improve patient outcomes in numerous clinical situations. It is one of the smallest available biosensors and transmits data to a cloud platform using a data hub or smartphone. Altair’s technology will be able to accurately monitor very large numbers of patients in any location simultaneously. Alba Equity led the investment syndicate in the company’s first external funding round totalling £2.25m in April 2021.